The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV/HIV infected subjects.
Macrophage activation plays a key role in liver disease progression. Soluble CD163 (sCD163) is a specific macrophage activation biomarker useful for clinical estimating damage severity and predicting outcome in different liver conditions. sCD163 performance as a non-invasive marker of liver damage w...
Saved in:
| Main Authors: | Victoria Cairoli, Elena De Matteo, Paola Casciato, Beatriz Ameigeiras, María Victoria Preciado, Pamela Valva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0270911&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study
by: Victoria Cairoli, et al.
Published: (2025-06-01) -
Soluble CD 163: A novel biomarker
by: Rajeev B Ahuja
Published: (2011-01-01) -
Soluble CD 163: A novel biomarker
by: Rajeev B. Ahuja
Published: (2011-01-01) -
The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology
by: Andriana Plevriti, et al.
Published: (2024-10-01) -
Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.
by: Lauren E Kushner, et al.
Published: (2013-01-01)